Diagnosis and Classification of Pulmonary Hypertension in 2023

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Abbott Vascular; Edwards Lifesciences; Medtronic; Merck; Alleviant; CareDx; Cytokinetics; Itamar; Eidos; Lexicon; Gradient
• travel reimbursement - Abiomed
• Equity/Stock(s)/Options - Aria CV